This is so vastly different than adult onc/nephro isnt it? What makes the discrepancy so huge?
There's several issues. The payor difference is probably the biggest one (I'm about 70% Medicaid). There's also the inherent underpayment for all Peds services (thanks AAP!). We also tend to be employed by hospital systems, and don't own/run our own infusion centers, which is where a lot of adult oncs make their money. In fairness, the adult oncs do tend to see a lot more volume than we do (although ours tend to be higher acuity).
Which does not even cover the cost of the high priced cancer drugs.
There are no high priced cancer drugs in Peds. We're still using the same old drugs from 30 years ago. (Ok, not totally true, but the targeted therapy revolution is only slowly trickling down to Peds. This may change once immunotherapy becomes widespread).
Leave a comment: